Despite the fact that Tregs suppress the cancer immune response via multiple pathways [34, 35], Tregs also express IFNγ, and IFNγ+ Tregs remain immunologically suppressive in the human colorectal cancer microenvironment [36, 37]. This evidence concerns the gene IFNG and cancer.